92 related articles for article (PubMed ID: 17544259)
1. Factors triggering abolishment of benzodiazepines effects in the Four-Plate Test--retest in mice.
Petit-Demoulière B; Hascoët M; Bourin M
Eur Neuropsychopharmacol; 2008 Jan; 18(1):41-7. PubMed ID: 17544259
[TBL] [Abstract][Full Text] [Related]
2. Temporal parameters of one-trial tolerance to benzodiazepines in four-plate test-retest.
Petit-Demouliere B; Bourin M
Behav Brain Res; 2007 Nov; 183(2):222-5. PubMed ID: 17628712
[TBL] [Abstract][Full Text] [Related]
3. Brain structures implicated in the four-plate test in naïve and experienced Swiss mice using injection of diazepam and the 5-HT2A agonist DOI.
Petit-Demoulière B; Massé F; Cogrel N; Hascoët M; Bourin M
Behav Brain Res; 2009 Dec; 204(1):200-5. PubMed ID: 19523493
[TBL] [Abstract][Full Text] [Related]
4. NMDA and D1 receptors are involved in one-trial tolerance to the anxiolytic-like effects of diazepam in the elevated plus maze test in rats.
Zhou H; Yu CL; Wang LP; Yang YX; Mao RR; Zhou QX; Xu L
Pharmacol Biochem Behav; 2015 Aug; 135():40-5. PubMed ID: 26004015
[TBL] [Abstract][Full Text] [Related]
5. Role of learning of open arm avoidance in the phenomenon of one-trial tolerance to the anxiolytic effect of chlordiazepoxide in mice.
Calzavara MB; Patti CL; Lopez GB; Abílio VC; Silva RH; Frussa-Filho R
Life Sci; 2005 Mar; 76(19):2235-46. PubMed ID: 15733938
[TBL] [Abstract][Full Text] [Related]
6. The four-plates test-retest paradigm to discriminate anxiolytic effects.
Ripoll N; Nic Dhonnchadha BA; Sébille V; Bourin M; Hascoët M
Psychopharmacology (Berl); 2005 Jun; 180(1):73-83. PubMed ID: 15918077
[TBL] [Abstract][Full Text] [Related]
7. A comparative study with two types of elevated plus-maze (transparent vs. opaque walls) on the anxiolytic effects of midazolam, one-trial tolerance and fear-induced analgesia.
Albrechet-Souza L; Oliveira AR; De Luca MC; Tomazini FM; Santos NR; Brandão ML
Prog Neuropsychopharmacol Biol Psychiatry; 2005 May; 29(4):571-9. PubMed ID: 15866360
[TBL] [Abstract][Full Text] [Related]
8. Anxiolytic-like effect of 5-HT(2) ligands and benzodiazepines co-administration: comparison of two animal models of anxiety (the four-plate test and the elevated plus maze).
Massé F; Nic Dhonnchadha BA; Hascoët M; Bourin M
Behav Brain Res; 2007 Feb; 177(2):214-26. PubMed ID: 17175036
[TBL] [Abstract][Full Text] [Related]
9. The four-plates test: anxiolytic or analgesic paradigm?
Ripoll N; Hascoët M; Bourin M
Prog Neuropsychopharmacol Biol Psychiatry; 2006 Jul; 30(5):873-80. PubMed ID: 16644084
[TBL] [Abstract][Full Text] [Related]
10. Implication of 5-HT2A subtype receptors in DOI activity in the four-plates test-retest paradigm in mice.
Ripoll N; Hascoët M; Bourin M
Behav Brain Res; 2006 Jan; 166(1):131-9. PubMed ID: 16154212
[TBL] [Abstract][Full Text] [Related]
11. Effect of noradrenergic system on the anxiolytic-like effect of DOI (5-HT2A/2C agonists) in the four-plate test.
Massé F; Hascoët M; Dailly E; Bourin M
Psychopharmacology (Berl); 2006 Jan; 183(4):471-81. PubMed ID: 16307296
[TBL] [Abstract][Full Text] [Related]
12. Amphetamine and pentylenetetrazole given post-trial 1 enhance one-trial tolerance to the anxiolytic effect of diazepam in the elevated plus-maze in mice.
Vargas KM; Da Cunha C; Andreatini R
Prog Neuropsychopharmacol Biol Psychiatry; 2006 Dec; 30(8):1394-402. PubMed ID: 16828217
[TBL] [Abstract][Full Text] [Related]
13. Effect of GABAergic ligands on the anxiolytic-like activity of DOI (a 5-HT(2A/2C) agonist) in the four-plate test in mice.
Massé F; Hascoët M; Bourin M
Eur Neuropsychopharmacol; 2007; 17(6-7):483-91. PubMed ID: 17196374
[TBL] [Abstract][Full Text] [Related]
14. The anterior cingulate cortex is a target structure for the anxiolytic-like effects of benzodiazepines assessed by repeated exposure to the elevated plus maze and Fos immunoreactivity.
Albrechet-Souza L; Borelli KG; Carvalho MC; Brandão ML
Neuroscience; 2009 Dec; 164(2):387-97. PubMed ID: 19699782
[TBL] [Abstract][Full Text] [Related]
15. Influence of prior maze experience on behaviour and response to diazepam in the elevated plus-maze and light/dark tests of anxiety in mice.
Rodgers RJ; Shepherd JK
Psychopharmacology (Berl); 1993; 113(2):237-42. PubMed ID: 7855188
[TBL] [Abstract][Full Text] [Related]
16. Increases in plasma corticosterone and stretched-attend postures in rats naive and previously exposed to the elevated plus-maze are sensitive to the anxiolytic-like effects of midazolam.
Albrechet-Souza L; Cristina de Carvalho M; Rodrigues Franci C; Brandão ML
Horm Behav; 2007 Aug; 52(2):267-73. PubMed ID: 17553501
[TBL] [Abstract][Full Text] [Related]
17. Anxiolytic-like effects of DOI microinjections into the hippocampus (but not the amygdala nor the PAG) in the mice four plates test.
Masse F; Petit-Demouliere B; Dubois I; Hascoët M; Bourin M
Behav Brain Res; 2008 Apr; 188(2):291-7. PubMed ID: 18155304
[TBL] [Abstract][Full Text] [Related]
18. Implication of 5-HT2 receptor subtypes in the mechanism of action of the GABAergic compound etifoxine in the four-plate test in Swiss mice.
Bourin M; Hascoët M
Behav Brain Res; 2010 Apr; 208(2):352-8. PubMed ID: 20006646
[TBL] [Abstract][Full Text] [Related]
19. Intra-periaqueductal gray matter injections of midazolam fail to alter anxiety in plus-maze experienced mice.
dos Reis LM; Canto-de-Souza A
Brain Res; 2008 Sep; 1231():93-102. PubMed ID: 18621039
[TBL] [Abstract][Full Text] [Related]
20. Blockade of the mineralocorticoid receptors in the medial prefrontal cortex prevents the acquisition of one-trial tolerance in mice.
Albernaz-Mariano KA; Souza RR; Canto-de-Souza A
Behav Brain Res; 2022 Aug; 431():113938. PubMed ID: 35618080
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
